Levonorgestrel-releasing Intrauterine System(LNG-IUS)

DEVICE2 trials

Sponsors

Fudan University

Conditions

Atypical Endometrial HyperplasiaEndometrial Neoplasm Malignant Stage I

Phase 2

Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer

CompletedNCT03241914

Fudan UniversityEndometrial Neoplasm Malignant Stage I

Start: 2017-07-04End: 2020-06-18Updated: 2020-11-20

Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia

CompletedNCT03241888

Fudan UniversityAtypical Endometrial Hyperplasia

Start: 2017-07-04End: 2020-06-18Updated: 2024-09-26

Related Papers

Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study.

2023-05-125 citations

Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (ClinicalTrials.gov NCT03241914)

Journal of Gynecologic Oncology2022-12-2211 citations

OP009/#222 Combined oral megestrol acetate/levonorgestrel-intrauterine system for atypical endometrial hyperplasia: a single-center prospective randomized controlled pilot study

2021-11-011 citations